GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human WEE1 kinase domain in complex with rac-IV- 016, a MK1775 analougue

Analyse Crystal structure of human WEE1 kinase domain in complex with rac-IV- 016, a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VD4
Type
protein
Length
261 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
WEE1-like protein kinase
EC
2.7.10.2
UniProt
P30291
Ligands
99J, PO4, CL
Pockets
4 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AWEE1-like protein kinase (EC 2.7.10.2)protein26141% helix, 21% strandP30291

Ligands and binding sites

  • 99J · 6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1-{6-[(1S)-2,2,2-trifluoro-1-hydroxyethyl]pyridin-2-yl}-1,2-dihydro-3H-pyrazolo[3, 4-d]pyrimidin-3-one · ligand · chains A
  • PO4 · Phosphate ion · ion · 2 copies · chains A
  • CL · Chloride ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13190.620.793799J
2780.360.7614EDO
3600.320.7613empty
4720.310.7412empty

Compared structures

  • 5VD4 · CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV-016, a MK1775… · the same entry in another collection · chain A against A, TM-score 1.00
  • P30291 · AlphaFold monomer V2.0 prediction for WEE1-like protein kinase (P30291) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.